drugset / Trial / NCT02092207
Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a controlled study to determine the effectiveness and safety of KL7016 in the treatment of adult patients with dry eye syndrome (DES).
Timeline
- Start
- 2012-10
- Primary completion
- 2014-06
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KL7016 | Unknown | 600 mg | Oral |
| Subject | KL7016 | Unknown | 900 mg | Oral |